MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$955,625
EPS
-$0.3
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Selling, general and administrative
988,501
1,027,179
-
990,737
Total operating expenses
988,501
1,027,179
-
990,737
Loss from operations
-988,501
-1,027,179
-
-990,737
Change in fair value of warrant liability
-900
-
-
-1,000
Interest income
31,976
40,143
-
67,014
Total other income (expenses)
32,876
40,143
-
68,014
Income (loss) before income taxes
-955,625
-987,036
-
-922,723
Income (loss) from continuing operations, net of tax
-955,625
-987,036
-54,049.5*
-922,723
Net income (loss)
-955,625
-987,036
-
-922,723
Preferred stock dividends, income statement impact
-
-
56,467,170*
231,210
Preferred stock, accretion of redemption discount
-
-
0*
-
Net income (loss) from continuing operations available to common shareholders, basic
-
-
-56,521,219.5
-1,153,933
Basic EPS
-0.3
-0.03
-2.014
-0.03
Diluted EPS
-0.3
-0.03
-2.014
-0.03
Basic Average Shares
47,391,733
46,222,502
28,065,362*
42,284,502
Diluted Average Shares
47,391,733
46,222,502
28,065,362*
42,284,502
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net income (loss)
-$955,625
(-117.59%↓ Y/Y)
Income (loss) from
continuing operations, net...
-$955,625
(53.18%↑ Y/Y)
Interest income
$31,976
(-64.01%↓ Y/Y)
Change in fair value of
warrant liability
-$900
(-100.27%↓ Y/Y)
Income (loss) before
income taxes
-$955,625
(53.18%↑ Y/Y)
Total other income
(expenses)
$32,876
(113.67%↑ Y/Y)
Loss from operations
-$988,501
(45.11%↑ Y/Y)
Total operating
expenses
$988,501
(-45.11%↓ Y/Y)
Selling, general and
administrative
$988,501
(-45.11%↓ Y/Y)
Buy us a coffee
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)